EMEA-002427-PIP01-18-M01

Key facts

Active substance
valoctocogene roxaparvovec
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0148/2021
PIP number
EMEA-002427-PIP01-18-M01
Pharmaceutical form(s)
Solution for infusion
Condition(s) / indication(s)
Treatment of Haemophilia A
Route(s) of administration
Intravenous use
Contact for public enquiries
BioMarin International Limited

Tel. +44 2074200800
E-mail: biomarin-europe@bmrn.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
2 ratings